These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8861786)

  • 21. A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats.
    Kassa J; Karasova JZ; Tesarova S
    Drug Chem Toxicol; 2011 Jul; 34(3):233-9. PubMed ID: 21649476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
    Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
    Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
    Simons KJ; Briggs CJ
    J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Musilek K; Horova A
    Toxicol Mech Methods; 2014 Mar; 24(3):173-8. PubMed ID: 24295433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a sensitive HPLC method for the quantification of HI-6 in guinea pig plasma and evaluated in domestic swine.
    Bohnert S; Vair C; Mikler J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1407-13. PubMed ID: 20395179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HI-6 oxime (an acetylcholinesterase reactivator): blood plasma pharmacokinetics and organ distribution in experimental pigs.
    Kuneš M; Květina J; Bureš J; Karasová JZ; Pavlík M; Tachecí I; Musílek K; Kuca K
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():191-6. PubMed ID: 25638385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Bajgar J
    Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
    J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector.
    Nyberg AG; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Palmer L; Persson SA
    Biopharm Drug Dispos; 1995 Nov; 16(8):635-51. PubMed ID: 8573684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and effects of HI 6 in blood and brain of soman-intoxicated rats: a microdialysis study.
    Cassel G; Karlsson L; Waara L; Ang KW; Göransson-Nyberg A
    Eur J Pharmacol; 1997 Jul; 332(1):43-52. PubMed ID: 9298924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
    Worek F; Koller M; Thiermann H; Wille T
    Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acetylcholinesterase reactivator HI-6 (1-[[[4-(aminocarbonyl)pyridinio]methoxyl]methyl]- 2-[(hydroxyimino)methyl]-pyridinium dichloride): a comparative study of HI-6 samples from various sources.
    Clement JG; Lockwood PA; Thompson HG
    Arch Toxicol; 1988; 62(2-3):220-3. PubMed ID: 3196157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of the oxime, HI-6, in patients with acute organophosphorus insecticide poisoning].
    Jovanović D; Randelović S; Joksović D; Todorović V
    Vojnosanit Pregl; 1993; 50(1):27-31. PubMed ID: 8493783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.
    van Helden HP; van der Wiel HJ; Zijlstra JJ; Melchers BP; Busker RW
    Arch Toxicol; 1994; 68(4):224-30. PubMed ID: 8067894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effects of acetylcholinesterase reactivators on monoamine oxidase activity.
    Fišar Z; Hroudová J; Korábečný J; Musílek K; Kuča K
    Toxicol Lett; 2011 Mar; 201(2):176-80. PubMed ID: 21195145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.